Psychogastroenterology · autonomic testing

Psychogastroenterology in Practice: Measuring the Autonomic Side

Autonomic testing gives psychogastroenterology its objective record: stress-driven gut dysmotility registers on heart rate variability while pulse and blood pressure stay normal, and that is the physiology a psychotherapy referral otherwise leaves undocumented.

Brain-gut behavioral therapies carry randomized evidence that most gut-directed products lack. What is usually missing is an objective autonomic record beside the symptom score.

Psychogastroenterology has a referral problem written into its own guidance. The American College of Gastroenterology conditionally suggests gut-directed psychotherapies for irritable bowel syndrome, on very low quality evidence with a collective number needed to treat of 4, then advises that patients with comorbid mental health conditions, who respond less well, be referred to non-gastrointestinal mental health professionals (Lacy et al., 2021). The patient with the most autonomic load is the one most likely to leave the building.

In The Angry Gut, Dr. Gurpreet Singh Padda, MD, MBA, MHP, and Ami Michelle Grimes frame that gap, and the companion video Two Doctors, One Bowel, Nobody in Charge follows it through a patient with biopsy-proven Crohn’s disease and a trauma history. Measura [Cardiometabolic and Autonomic Health Analysis] is a testing service that returns findings to the ordering physician. Its contribution here is narrow and specific: an objective autonomic record beside the symptom score.

How does stress change gut motility?

Dr. Padda concedes he spent years using stress as a closing diagnosis after a clean endoscopy. The motility literature argues against that habit. In healthy volunteers with colonic manometry, psychological stress produced more propagated contractions and physical stress more simultaneous ones, with no regional differences; only the physical stressor raised pulse and blood pressure, and colonic activity stayed elevated after the psychological stressor ended (Rao et al., 1998).

Electrogastrography adds the autonomic link. Stress abolished the postprandial rise in gastric myoelectrical activity and dropped the percentage of normal slow waves from 82.0% to 66.0%, while spectral heart rate variability showed vagal inhibition and rising sympathetic activity at the same time (Yin et al., 2004). Acute auditory stress lengthened gastric half-emptying from 105.0 to 130.8 minutes with accommodation preserved (Lee et al., 2013), in eight subjects, seven of them men. In 18 healthy subjects, vagal stimulation raised cardiac vagal tone against sham, p = 0.009, along with antral contraction frequency, p = 0.004 (Frøkjaer et al., 2016).

The clinical reading: pulse and blood pressure are too coarse to register stress-driven dysmotility, while HRV-level measures tracked it under laboratory conditions. None of these studies enrolled patients, and the patient trial the vagal authors requested has not been run.

Which GI patients carry the most autonomic load?

Across 8 studies and 648,375 subjects, PTSD and IBS associated at a pooled odds ratio of 2.80 (Ng et al., 2019). Post-infectious cohorts identify the host state as the predictor. In Walkerton, prior anxiety or depression predicted persistent IBS, with odds of 3.12 against unexposed residents at eight years (Marshall et al., 2010). After the German outbreak, somatization and anxiety scores survived the model and acute disease severity did not (Andresen et al., 2016). In two tertiary IBS samples of 231 and 141, somatization mediated most visceral sensitivity on barostat testing, though abuse history retained an independent effect on some parameters (Grinsvall et al., 2018).

Two biological drivers converge. One is vagal withdrawal with sympathetic predominance, the state the motility studies captured. The second is an inflammatory threshold: in 2,555 Marines, pre-deployment CRP predicted whether PTSD symptoms emerged, with an odds ratio of 1.51 per 10-fold increment, but not their severity (Eraly et al., 2014), and in a metabolically loaded population metaflammation is a common source of that baseline. The third driver is organizational. Gastroenterology and psychiatry run separate schedules, and a patient shared between them is owned by neither.

Practical selection criteria for autonomic testing in a GI or primary care population:

• Functional GI symptoms that persist after a structural and inflammatory workup is negative.
• Inflammatory bowel disease with pain between flares despite normal markers.
• Symptom onset after an enteric infection.
• A documented trauma history, PTSD, anxiety or depression alongside GI symptoms.

What can autonomic tests measure in a GI patient, and what can’t they?

Heart rate variability quantifies beat-to-beat variation as an index of vagal and sympathetic balance. Cardiac autonomic reflex tests record heart rate and blood pressure responses to standardized maneuvers such as paced breathing and standing. Autonomic nervous system testing extends the assessment of autonomic regulation more broadly.

None of these diagnoses IBS, distinguishes functional from inflammatory disease, or substitutes for Rome criteria and a gastroenterology workup. An abnormal result describes the autonomic state of a patient who already carries a GI diagnosis; a normal result does not exclude a brain-gut disorder. Stool microbiome profiling and blood permeability panels are different tests performed elsewhere, and both carry validity problems: host variables such as bowel movement quality confound microbiome case-control comparisons (Vujkovic-Cvijin et al., 2020), and the most widely used commercial zonulin ELISA did not detect its named target (Scheffler et al., 2018).

Because the adversity-to-inflammation path in adult women ran through body weight (Hantsoo et al., 2026), bioimpedance body composition is a reasonable metabolic companion measure where adiposity is in question.

What does an autonomic finding change in GI management?

It does not change disease-directed GI therapy. A patient with Crohn’s disease stays on the biologic that controls flares. What it changes is the case for delivering brain-gut behavioral care early and in the same practice. A network meta-analysis of 67 randomized trials (7,441 patients) found behavioral therapies, including CBT and gut-directed hypnotherapy, outperformed waiting-list control on global IBS symptoms (Thakur et al., 2025). Telephone CBT lowered symptom severity by 61.6 points against usual care at 12 months in 558 patients (Everitt et al., 2019). Gut-directed hypnotherapy matched the low FODMAP diet on symptoms and alone improved trait anxiety and depression (Peters et al., 2016).

Body-based methods sit at a lower tier: no breath-based or somatic trial has reported a primary bowel endpoint, and those trials have not enrolled the patient with inflammatory disease, trauma and pain. The practice position uses them on mechanism. A documented autonomic baseline gives the treating team an objective reference before therapy begins and a comparison point afterward, without implying that the value itself is the treatment target. The cortisol and HPA side is covered in HPA axis dysfunction in chronic pain.

Psychogastroenterology workflow and documentation

A standing order keyed to a negative GI workup plus persistent symptoms makes autonomic testing reproducible rather than clinician-dependent. Results should land in the chart as structured data; see getting results into the record. The metabolic and cognitive counterpart is screening the drivers of blood-brain barrier dysfunction, the patient version is written for the person with the symptoms, and the full evidence with its limits is in the Chapter 13 Deep Dive.

Frequently asked questions

Does abnormal heart rate variability support an IBS diagnosis?

No. HRV and cardiac autonomic reflex tests describe autonomic balance and reflex integrity; they carry no diagnostic specificity for IBS or inflammatory bowel disease. IBS remains a clinical diagnosis made from symptom criteria and an appropriate workup. An abnormal autonomic result documents a physiological state relevant to management in a patient whose GI diagnosis is already established. See how the report is structured and read.

Which gastroenterology patients are reasonable candidates for autonomic testing?

Patients whose symptoms persist after a negative structural and inflammatory workup, those with inflammatory bowel disease and pain between flares despite normal markers, post-infectious onset, or comorbid PTSD, anxiety or depression. Post-infectious cohorts found that pre-existing anxiety and somatization, not infection severity, predicted who developed lasting IBS. Review specialty applications by practice type.

Should a zonulin level or stool microbiome report guide a behavioral referral?

The evidence does not support it. In veterans, seven blood permeability markers did not track PTSD severity or correlate with each other, and a widely used zonulin assay failed to detect its target. Microbiome case-control signals collapse when cases and controls are matched on host variables. Symptom burden and clinical history are firmer grounds. Read the clinical rationale behind the protocol.

How durable are brain-gut behavioral therapies?

Reasonably durable, with decay in some patients. In the largest CBT trial, 436 patients, mean symptom reductions were about -76 immediately and -94 at 12 months against a 50-point threshold for clinical significance. Telephone CBT maintained a 61.6-point advantage over usual care at a year. Planned re-assessment catches the patients who relapse between visits. See between-visit monitoring options.

Who in the practice runs the testing?

Autonomic protocols are standardized maneuvers performed by trained staff under physician supervision, with interpretation returned to the ordering clinician. Scheduling them alongside the GI follow-up visit, rather than as a separate referral, keeps the patient inside one team, which is the gap the guideline language leaves open. Review staffing and workflow requirements.

What is psychogastroenterology?

It is the brain-gut side of digestive care. It treats disorders such as irritable bowel syndrome with behavioral therapies aimed at the nervous system, including cognitive behavioral therapy and gut-directed hypnotherapy, and the American College of Gastroenterology suggests these therapies for IBS. What the field usually lacks is an objective record of the nervous system, which is where heart rate variability and autonomic testing fit.

What does a gastro psychologist do?

A GI psychologist delivers brain-gut behavioral therapies. Across 67 randomized trials with 7,441 patients, therapies including cognitive behavioral therapy and gut-directed hypnotherapy did better than a waiting list on overall IBS symptoms. In one trial, gut-directed hypnotherapy matched the low FODMAP diet on symptoms and, alone, improved anxiety and depression. It does not replace disease treatment: a patient with Crohn’s disease stays on the biologic that controls flares.

When would you go to a GI psychologist?

When digestive symptoms persist after a scope and blood work find no structural or inflammatory cause, when symptoms began after a gut infection, or when anxiety, depression, PTSD or a trauma history sits alongside the gut symptoms. Our position is that this care should start early and in the same practice, because a patient shared between gastroenterology and psychiatry is too often owned by neither.

References

• Lacy, B. E., Pimentel, M., Brenner, D. M., Chey, W. D., Keefer, L. A., Long, M. D., & Moshiree, B. (2021). ACG clinical guideline: management of irritable bowel syndrome. The American Journal of Gastroenterology, 116(1), 17-44. https://doi.org/10.14309/ajg.0000000000001036
• Rao, S. S., Hatfield, R. A., Suls, J. M., & Chamberlain, M. J. (1998). Psychological and physical stress induce differential effects on human colonic motility. The American Journal of Gastroenterology, 93(6), 985-990. https://doi.org/10.1111/j.1572-0241.1998.00293.x
• Yin, J., Levanon, D., & Chen, J. D. Z. (2004). Inhibitory effects of stress on postprandial gastric myoelectrical activity and vagal tone in healthy subjects. Neurogastroenterology and Motility, 16(6), 737-744. https://doi.org/10.1111/j.1365-2982.2004.00544.x
• Lee, H. S., An, Y.-S., Kang, J., Yoo, J. H., & Lee, K. J. (2013). Effect of acute auditory stress on gastric motor responses to a meal in healthy volunteers. Journal of Gastroenterology and Hepatology, 28(11), 1699-1704. https://doi.org/10.1111/jgh.12309
• Frøkjaer, J. B., Bergmann, S., Brock, C., Madzak, A., Farmer, A. D., Ellrich, J., & Drewes, A. M. (2016). Modulation of vagal tone enhances gastroduodenal motility and reduces somatic pain sensitivity. Neurogastroenterology and Motility, 28(4), 592-598. https://doi.org/10.1111/nmo.12760
• Ng, Q. X., Soh, A. Y. S., Loke, W., Venkatanarayanan, N., Lim, D. Y., & Yeo, W.-S. (2019). Systematic review with meta-analysis: The association between post-traumatic stress disorder and irritable bowel syndrome. Journal of Gastroenterology and Hepatology, 34(1), 68-73. https://doi.org/10.1111/jgh.14446
• Andresen, V., Löwe, B., Broicher, W., Riegel, B., Fraedrich, K., von Wulffen, M., Gappmayer, K., Wegscheider, K., Treszl, A., Rose, M., Layer, P., & Lohse, A. W. (2016). Post-infectious irritable bowel syndrome (PI-IBS) after infection with Shiga-like toxin-producing Escherichia coli (STEC) O104:H4: A cohort study with prospective follow-up. United European Gastroenterology Journal, 4(1), 121-131. https://doi.org/10.1177/2050640615581113
• Grinsvall, C., Törnblom, H., Tack, J., Van Oudenhove, L., & Simrén, M. (2018). Relationships between psychological state, abuse, somatization and visceral pain sensitivity in irritable bowel syndrome. United European Gastroenterology Journal, 6(2), 300-309. https://doi.org/10.1177/2050640617715851
• Eraly, S. A., Nievergelt, C. M., Maihofer, A. X., Barkauskas, D. A., Biswas, N., Agorastos, A., O’Connor, D. T., & Baker, D. G. (2014). Assessment of plasma C-reactive protein as a biomarker of posttraumatic stress disorder risk. JAMA Psychiatry, 71(4), 423-431. https://doi.org/10.1001/jamapsychiatry.2013.4374
• Thakur, E. R., Khasawneh, M., Moayyedi, P., Black, C. J., & Ford, A. C. (2025). Efficacy of behavioural therapies for irritable bowel syndrome: a systematic review and network meta-analysis. The Lancet Gastroenterology & Hepatology, 10(12), 1075-1088. https://doi.org/10.1016/S2468-1253(25)00238-9

Related reading

• Blood-Brain Barrier Dysfunction: Screening the Metabolic Drivers
• Short-Chain Fatty Acids: Why a Fecal Panel Misleads
• Heart Rate Variability

Medically reviewed by Dr. Gurpreet Singh Padda, MD, MBA, MHP, medical director of Measura. Last reviewed September 12, 2026.